Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats.
Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats.
复制标题
DOI:
10.1371/journal.pone.0011383
复制
发表时间:
2010-06-30
期刊:
影响因子:
3.7
通讯作者:
Moore AN
中科院分区:
文献类型:
--
作者:
Dash PK;Orsi SA;Zhang M;Grill RJ;Pati S;Zhao J;Moore AN
Traumatic brain injury (TBI) initiates a complex series of neurochemical and signaling changes that lead to pathological events including neuronal hyperactivity, excessive glutamate release, inflammation, increased blood-brain barrier (BBB) permeability and cerebral edema, altered gene expression, and neuronal dysfunction. It is believed that a drug combination, or a single drug acting on multiple targets, may be an effective strategy to treat TBI. Valproate, a widely used antiepileptic drug, has a number of targets including GABA transaminase, voltage-gated sodium channels, glycogen synthase kinase (GSK)-3, and histone deacetylases (HDACs), and therefore may attenuate a number of TBI-associated pathologies. Using a rodent model of TBI, we tested if post-injury administration of valproate can decrease BBB permeability, reduce neural damage and improve cognitive outcome. Dose-response studies revealed that systemic administration of 400 mg/kg (i.p.), but not 15, 30, 60 or 100 mg/kg, increases histone H3 and H4 acetylation, and reduces GSK-3 activity, in the hippocampus. Thirty min post-injury administration of 400 mg/kg valproate improved BBB integrity as indicated by a reduction in Evans Blue dye extravasation. Consistent with its dose response to inhibit GSK-3 and HDACs, valproate at 400 mg/kg, but not 100 mg/kg, reduced TBI-associated hippocampal dendritic damage, lessened cortical contusion volume, and improved motor function and spatial memory. These behavioral improvements were not observed when SAHA (suberoylanilide hydroxamic acid), a selective HDAC inhibitor, was administered. Our findings indicate that valproate given soon after TBI can be neuroprotective. As clinically proven interventions that can be used to minimize the damage following TBI are not currently available, the findings from this report support the further testing of valproate as an acute therapeutic strategy.
登录
查看更多内容
影响因子:
3.3
作者:
Hoskison MM;Moore AN;Hu B;Orsi S;Kobori N;Dash PK
通讯作者:
Dash PK
影响因子:
3.8
作者:
Alam, Hasan B.;Shuja, Fahad;Velmahos, George C.
通讯作者:
Velmahos, George C.
影响因子:
5.3
作者:
Hao, YL;Creson, T;Chen, G
通讯作者:
Chen, G
影响因子:
11.4
作者:
Göttlicher, M;Minucci, S;Heinzel, T
通讯作者:
Heinzel, T
影响因子:
3.1
作者:
Gonzales, E;Chen, HZ;Koustova, E
通讯作者:
Koustova, E